ADAR1 Capital Management »

Solid Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Solid Biosciences (SLDB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Solid Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Solid Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Solid Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.0M 1.1M 6.97
2024-06-30 $8.1M 1.4M 5.67
2024-03-31 $2.7M 203k 13.32
2023-12-31 $6.1k 1.0k 6.14

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Solid Biosciences

Perceptive Advisors
RA Capital Management
Bain Capital Life Sciences Investors
Vestal Point Capital
Siren
Adage Capital Partners GP
BlackRock
Vanguard Group
ADAR1 Capital Management
Millennium Management
Citadel Advisors
Finepoint Capital
Geode Capital Management
Monashee Investment Management
Silverarc Capital Management

View all funds holding Solid Biosciences